Propranolol and Fertility
Propranolol can be safely continued in men trying to conceive, but should be avoided in women of reproductive age who are planning pregnancy or are pregnant, with preferred alternatives being labetalol, methyldopa, or long-acting nifedipine.
Effects on Male Fertility
Propranolol does not require discontinuation in men attempting to conceive. While animal studies have shown potential adverse effects on male reproductive parameters at high doses 1, 2, there is insufficient clinical evidence linking propranolol use to male infertility in humans at therapeutic doses 3. The FDA label notes that propranolol studies in rats at doses up to 50 mg/kg (less than the maximum recommended human dose) showed no effects on fertility 4.
Key Considerations for Men:
- Animal studies demonstrated decreased sperm motility, density, and testosterone levels only at doses of 15 mg/kg body weight 1, 2
- These effects were reversible after discontinuation 2
- No compelling human data supports routine discontinuation in men trying to conceive 3
- If fertility concerns arise, consider switching to alternative antihypertensives rather than stopping treatment entirely
Effects on Female Fertility and Pregnancy
Women planning pregnancy should discontinue propranolol and switch to pregnancy-compatible alternatives before conception. Beta-blockers, particularly atenolol, have been associated with intrauterine growth retardation, though propranolol has a more favorable profile than atenolol 5.
Preferred Alternatives for Women:
First-line agents for women of reproductive age:
- Labetalol (oral): Most commonly recommended, well-tolerated 6, 7, 8
- Methyldopa (oral): Preferred based on long-term safety data, though less well-tolerated due to side effects 5, 7
- Long-acting nifedipine (oral): Increasingly preferred, once-daily dosing 6, 7, 8
Second-line options:
- Other beta-blockers (acebutolol, metoprolol, pindolol, propranolol) are acceptable but less preferred 6
- Hydralazine 6
- Thiazide diuretics (may reduce milk volume during lactation) 5
Critical Contraindications:
Absolutely avoid in pregnancy:
- ACE inhibitors and ARBs (fetotoxic to renal system) 6, 5, 9, 6, 7
- Atenolol (associated with fetal growth restriction) 5, 7, 8
- Mineralocorticoid receptor antagonists 7
- Direct renin inhibitors 7
Preconception Counseling
All women with hypertension of reproductive age should receive preconception counseling 6. This includes:
- Assessment of medication safety and switching to pregnancy-compatible agents before attempting conception 6
- Discussion of low-dose aspirin (81 mg daily) to reduce preeclampsia risk 7
- Evaluation of baseline blood pressure control and target organ damage 5
Pregnancy Management
If a woman becomes pregnant while taking propranolol:
- Switch immediately to labetalol, methyldopa, or long-acting nifedipine 6, 7
- Target diastolic blood pressure of 85 mm Hg for chronic or gestational hypertension 6
- Severe hypertension (≥160/110 mm Hg) requires urgent treatment within 30-60 minutes 6, 7
Neonatal Monitoring:
The FDA label warns that neonates whose mothers received propranolol at delivery may exhibit bradycardia, hypoglycemia, and/or respiratory depression, requiring adequate monitoring facilities at birth 4.
Lactation
Propranolol is excreted in breast milk and should be used with caution during breastfeeding 4. Preferred alternatives during lactation include:
- Labetalol (though less effective postpartum than calcium channel blockers) 8
- Nifedipine or amlodipine (once-daily dosing advantage) 8
- Enalapril (ACE inhibitors acceptable postpartum if not breastfeeding concerns exist) 8
Clinical Algorithm
For women of reproductive age on propranolol:
- Assess pregnancy plans at every visit
- If planning pregnancy: Switch to labetalol, methyldopa, or long-acting nifedipine before conception 6
- If pregnant: Immediate switch to pregnancy-compatible agent 6, 7
- Ensure reliable contraception if continuing propranolol 8
For men on propranolol: